Patients with diabetes admitted to a tertiary care center for diabetic foot ulceration during the COVID-19 lockdown in Italy had a more than threefold risk for amputation versus patients seen in 2019.
Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.
Deep learning has shown substantial promise to date in automated image analysis towards the accurate diagnosis of diabetic retinopathy.
Higher intakes of vitamin C and carotenoids, as well as total whole grains, are associated with a lower risk for type 2 diabetes.
Increased dietary fiber intake, whether from a high-fiber diet or supplementation, plays little role in improving glycemic control in type 2 diabetes.
The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.
The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
A consensus statement outlines the benefits and barriers associated with diabetes self-management education and support (DSMES) in adults with type 2 diabetes.
Specifically, unacceptable levels of this potentially carcinogenic impurity have been identified in products manufactured by 5 different firms.
Careful consideration should be taken before using hydroxychloroquine in patients with diabetes, particularly in the context of COVID-19.
